Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Healthtrust
McKesson
Teva
Farmers Insurance
Chubb
Boehringer Ingelheim
Fuji
Merck
Express Scripts

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,541,350

« Back to Dashboard

Summary for Patent: 7,541,350
Title:Formulation containing anti-inflammatory androstane derivative
Abstract:There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) ##STR00001## or a solvate thereof.
Inventor(s): Biggadike; Keith (Stevenage, GB), Sayani; Amyn Pyarali (Mississauga, CA), Buxton; Ian Richard (Mississauga, CA), Reed; Kenton Lewis (Mississauga, CA)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:10/918,779
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

Drugs Protected by US Patent 7,541,350

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxosmithkline Cons FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051-002 Aug 2, 2016 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y OTC USE: ALLERGY SYMPTOM RELIEVER; TEMPORARILY RELIEVES THESE SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; NASAL CONGESTION, RUNNY NOSE, SNEEZING, ITCHY NOSE, AND (ITCHY WATER EYES (AGES 12 AND UP)) ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,541,350

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0019172.6Aug 05, 2000

Non-Orange Book US Patents Family Members for Patent 7,541,350

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,321 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents ➤ Try a Free Trial
6,537,983 Anti-inflammatory androstane derivatives ➤ Try a Free Trial
6,777,399 Anti-inflammatory androstane derivative compositions ➤ Try a Free Trial
6,878,698 Anti-inflammatory androstane derivatives ➤ Try a Free Trial
7,144,845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative ➤ Try a Free Trial
6,777,400 Anti-inflammatory androstane derivative compositions ➤ Try a Free Trial
6,858,593 Anti-inflammatory androstane derivative compositions ➤ Try a Free Trial
7,101,866 Anti-inflammatory androstane derivative ➤ Try a Free Trial
6,858,596 Formulation containing anti-inflammatory androstane derivative ➤ Try a Free Trial
6,787,532 Formulation containing anti-inflammatory androstane derivatives ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,541,350

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 77656 ➤ Try a Free Trial
Taiwan 200400837 ➤ Try a Free Trial
Taiwan 200302831 ➤ Try a Free Trial
Taiwan I284646 ➤ Try a Free Trial
Taiwan I244486 ➤ Try a Free Trial
Slovakia 287576 ➤ Try a Free Trial
Slovakia 1422003 ➤ Try a Free Trial
Slovenia 2348032 ➤ Try a Free Trial
Slovenia 1775305 ➤ Try a Free Trial
Slovenia 1539796 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
AstraZeneca
Healthtrust
Chubb
Dow
Deloitte
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot